Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 2
1971 1
1972 1
1973 3
1974 3
1975 5
1976 6
1977 1
1978 5
1979 2
1980 7
1981 4
1982 3
1983 2
1984 1
1985 1
1986 2
1987 7
1988 4
1989 3
1990 4
1991 12
1992 5
1993 6
1994 7
1995 4
1996 7
1997 8
1998 9
1999 4
2000 7
2001 6
2002 9
2003 7
2004 14
2005 7
2006 7
2007 14
2008 3
2009 3
2010 3
2011 4
2012 7
2013 7
2014 3
2015 4
2016 5
2017 10
2018 4
2019 9
2020 12
2021 5
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

273 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group. Green JB, et al. Among authors: standl e. N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. N Engl J Med. 2015. PMID: 26052984 Free article. Clinical Trial.
Issues for the management of people with diabetes and COVID-19 in ICU.
Ceriello A, Standl E, Catrinoiu D, Itzhak B, Lalic NM, Rahelic D, Schnell O, Škrha J, Valensi P; “Diabetes and Cardiovascular Disease (D&CVD)” Study Group of the European Association for the Study of Diabetes (EASD). Ceriello A, et al. Among authors: standl e. Cardiovasc Diabetol. 2020 Jul 20;19(1):114. doi: 10.1186/s12933-020-01089-2. Cardiovasc Diabetol. 2020. PMID: 32690029 Free PMC article. Review.
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J; PROactive Investigators. Dormandy JA, et al. Among authors: standl e. Lancet. 2005 Oct 8;366(9493):1279-89. doi: 10.1016/S0140-6736(05)67528-9. Lancet. 2005. PMID: 16214598 Free article. Clinical Trial.
Heart failure outcomes and Covid-19.
Standl E, Schnell O. Standl E, et al. Diabetes Res Clin Pract. 2021 May;175:108794. doi: 10.1016/j.diabres.2021.108794. Epub 2021 Apr 5. Diabetes Res Clin Pract. 2021. PMID: 33831494 Free PMC article.
Dysglycemia and abdominal obesity.
Standl E. Standl E. Curr Vasc Pharmacol. 2012 Nov;10(6):678-9. doi: 10.2174/157016112803520936. Curr Vasc Pharmacol. 2012. PMID: 23259551 Review.
Report from the 5th cardiovascular outcome trial (CVOT) summit.
Schnell O, Standl E, Cos X, Heerspink HJ, Itzhak B, Lalic N, Nauck M, Ceriello A. Schnell O, et al. Among authors: standl e. Cardiovasc Diabetol. 2020 Apr 17;19(1):47. doi: 10.1186/s12933-020-01022-7. Cardiovasc Diabetol. 2020. PMID: 32303223 Free PMC article.
[Type 2 diabetes].
Mehnert H, Standl E. Mehnert H, et al. Among authors: standl e. Internist (Berl). 1998 Apr;39(4):381-97. doi: 10.1007/s001080050186. Internist (Berl). 1998. PMID: 9599750 Review. German. No abstract available.
Hypoglycaemia and its management in primary care setting.
Ibrahim M, Baker J, Cahn A, Eckel RH, El Sayed NA, Fischl AH, Gaede P, Leslie RD, Pieralice S, Tuccinardi D, Pozzilli P, Richelsen B, Roitman E, Standl E, Toledano Y, Tuomilehto J, Weber SL, Umpierrez GE. Ibrahim M, et al. Among authors: standl e. Diabetes Metab Res Rev. 2020 Nov;36(8):e3332. doi: 10.1002/dmrr.3332. Epub 2020 May 18. Diabetes Metab Res Rev. 2020. PMID: 32343474 Review.
273 results